Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: J Magn Reson Imaging. 2018 May 7;48(6):1626–1636. doi: 10.1002/jmri.26178

Table 1.

Patient Specific Parameters

Institution 1 Institution 2

Parameter BCR+ (N = 35) BCR− (N = 35) BCR+ (N = 7) BCR− (N = 43)
MRI Receiver coils
 ERC n = 20 n = 35 n = 0 n = 0
 PPAC/Surface coil n = 15 n = 0 n = 7 n = 43
Clinical parameters
 Mean age (range) 62.4 (45–78) y 58 (46–80) y 62.6 (53 – 68) y 62.9 (54 – 72) y
 Mean pretreatment PSA (range) 20.9 (0.37 – 48.5) ng/mL 7.1 (0.03 – 21) ng/mL 12.97 (6–26) ng/mL 9.37 (3.5–35) ng/mL
 Median Gleason score (range) 9 (7 – 9) 7 (6 – 9) 7 (7 – 9) 7 (5 – 9)
 Mean follow-up time (range) 17.2 (0–59) mo 60 (25–85) mo 17 (11 – 30) mo 28.83 (3 – 67) mo
 Median PIRADS (range) 5 (2 – 5) 4 (2 – 5) 5 (4 – 5) 5 (1 – 5)
Treatment type
 Radical prostatectomy n = 22 n = 34 n = 7 n = 43
 Radiotherapy n = 10 n = 0 n = 0 n = 0
 LHRH n = 3 n = 1 n = 0 n = 0

Note: ERC = Endo-rectal coil, PPAC = Pelvic-phased array coil, PSA = prostate-specific antigen, LHRH = luteinizing hormone-releasing hormone therapy